Intracellular thyroid hormone metabolism as a local regulator of nuclear thyroid hormone receptor-mediated impact on vertebrate development by Darras, Veerle et al.
Biochimica et Biophysica Acta 1849 (2015) 130–141
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r .com/ locate /bbagrmReviewIntracellular thyroid hormone metabolism as a local regulator of nuclear
thyroid hormone receptor-mediated impact on
vertebrate development☆Veerle M. Darras ⁎, Anne M. Houbrechts, Stijn L.J. Van Herck
Laboratory of Comparative Endocrinology, Department of Biology, Division of Animal Physiology and Neurobiology, KU Leuven, B-3000 Leuven, BelgiumAbbreviations:D1, D2, D3, iodothyronine deiodinase ty
KO, knockout; LAT1, LAT2, L-type amino acid transporters
carboxylate transporters 8 and 10; OATP1C1, organic anio
TH, thyroid hormone; TRα, TRβ, thyroid hormone recepto
☆ This article is part of a Special Issue entitled:Nuclear re
⁎ Corresponding author at: Laboratory of Comparative E
P.O. Box 2464, B-3000 Leuven, Belgium. Tel.: +32 16 323
E-mail address: veerle.darras@bio.kuleuven.be (V.M. D
http://dx.doi.org/10.1016/j.bbagrm.2014.05.004
1874-9399/© 2014 Elsevier B.V. All rights reserved.a b s t r a c ta r t i c l e i n f oArticle history:
Received 20 February 2014
Received in revised form 17 April 2014
Accepted 7 May 2014
Available online 17 May 2014
Keywords:
Thyroid hormone
Iodothyronine deiodinase
TH transporter
Development
Vertebrate
Review
Background: Thyroid hormones (THs) play an essential role in vertebrate development, acting predominantly via
nuclear TH receptors (TRs)which are ligand-dependent transcription factors. Binding of the ligand (predominantly
T3) induces a switch from gene activation to gene repression or vice versa. Iodothyronine deiodinases (Ds) and
TH transporters are important regulators of intracellular T3 availability and therefore contribute to the control of
TR-dependent development.
Focus: The present review discusses the possible roles of Ds and TH transporters in regulating embryonic and larval
(pre-juvenile) TR-dependent development in vertebrates. It focuses mainly on well-known model species for di-
rect and indirect vertebrate development, including zebrafish, Xenopus, chicken and mouse. Data are provided
on stage- and tissue/cell-specific changes in expression of Ds and TH transporters. This information is combined
with functional data obtained from gain-and-loss of function studies.
Conclusion: Knockout/knockdown of each type of D has provided strong evidence for their implication in the con-
trol of important developmental processes and several D expression patterns and functions have been conserved
throughout vertebrate evolution. Knockout/knockdown of the inactivating D3 enzyme indicates that a premature
switch from unliganded to liganded TR action is often more detrimental than a delayed one. The majority of onto-
genetic studies on TH transporter distribution and function have focused on brain development, showing variable
impact of knockout/knockdown depending on the species. Future research in different models using conditional
silencing will hopefully further improve our understanding on how TH transporters, Ds and TRs cooperate to reg-
ulate TR-mediated impact on vertebrate development. This article is part of a Special Issue entitled: Nuclear recep-
tors in animal development.© 2014 Elsevier B.V. All rights reserved.1. Introduction
Thyroid hormones (THs) play an essential role in vertebrate devel-
opment. As a result, TH deficiency not only delays normal development,
but it also results in irreversible lifelong defects, especially in the ner-
vous system. In vertebrates with a clear metamorphosis, such as am-
phibians and many fish, TH deficiency will even stop progress from a
larva into a juvenile and eventually result in death. THs mainly act
by binding to nuclear TH receptors (TRs) that control transcription of
TH-responsive genes. Many of them are important regulators of devel-
opmental processes, including cell division, differentiation, migrationpes 1, 2, and 3; KD, knockdown;
1 and 2; MCT8, MCT10, mono-
n transporting polypeptide 10;
rs α and β
ceptors in animal development.
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arras).and apoptosis. Vertebrates have two types of nuclear TRs, TRα and
TRβ, encoded by thra and thrb respectively. Each gene can give rise to
different receptor isoforms via alternative splicing and each isoform
has specific functions [1,2]. However, almost all hormone binding TRs
have a higher affinity for 3,5,3′-triiodothyronine (T3) as compared to
3,5,3′,5′-tetraiodothyronine or thyroxine (T4), making T3 the predomi-
nant hormone active at the level of the nuclear TRs in most vertebrates.
Teleosts were recently shown to have two variants of TRβ1. While the
short variant predominantly binds T3, the long variant binds with high
affinity to 3,5-diiodothyronine (3,5-T2) and both hormones are physio-
logically relevant in regulating gene expression [3,4].
2. Need for local regulation of TH availability
The only cells capable of producing THs are the follicular cells of the
thyroid gland. This gland mainly releases T4 while T3 is released in
minor amounts. During the early stages of development, embryos are
not yet able to synthesize their own THs. They therefore rely on mater-
nal THs that are deposited in the yolk or supplied via the placenta in the
131V.M. Darras et al. / Biochimica et Biophysica Acta 1849 (2015) 130–141case of mammals. As development progresses and the embryonic thy-
roid gland starts functioning, the relative contribution of maternal THs
gradually declines. Maternal and embryonic THs are transported via
the circulation throughout the body to reach the different tissues and
the amount of hormone in circulation changes according to a species-
specific ontogenetic pattern. However, embryonic or larval tissues do
not all develop in the sameway nor at the same rate. Therefore different
tissues/cell types need several mechanisms to modulate the impact of
circulating THs according to their specific needs at a given time.
One common mechanism to regulate local hormone action is by
changing the expression of hormone receptors. The expression of differ-
ent TRs indeed changes throughout development in a tissue-specific
way [5–7]. However, TRs not only function when bound to their ligand
since unliganded TRs also bind to TH-response elements (TREs) in the
promotor region of TH-responsive genes. In case of a positive TRE, bind-
ing of the ligand can acutely reverse TR impact from repression to stim-
ulation of gene transcriptionwhile in case of a negative TRE the opposite
may occur [2,8,9]. Changes in intracellular ligand availability are there-
fore an essential level to regulate TR-mediated action. Intracellular
iodothyronine deiodinases are important in this process since these en-
zymes can locally produce or degrade T3 as well as 3,5-T2 [4]. TH trans-
porters located in the plasma membrane are important as well, since
they control influx of THs into the cell as well as TH efflux (Fig. 1). The
present review focuses on the role of changes in iodothyronine
deiodinases and TH transporters in vertebrate development, while
other reviews in this special issue on Nuclear Receptors in Animal
Development focus more specifically on the changes at the level of the
TRs.
3. Iodothyronine deiodinases and vertebrate development
Vertebrates possess three types of iodothyronine deiodinases (D1,
D2, D3) encoded by dio1, dio2 and dio3 respectively [10–12]. D1 is a
multifunctional enzyme that can cleave iodine from the outer as well
as the inner ring of an iodothyronine. It is a high Km enzyme that can
convert T4 into T3 and as such contributes to circulating T3 levels. Its pre-
ferred substrate is however reverse T3 (rT3) and studies in D1-deficient
mice suggest that D1 functions primarily as a scavenging enzyme, im-
portant in iodine recycling from inactive and lesser iodothyronines
[13,14]. D2 only catalyses outer ring deiodination (ORD); it is a low
Km enzyme with T4 as major substrate. It is important for local T3 pro-
duction in several tissues but also contributes to circulating T3, especial-
ly in fish and amphibians. It is also a likely candidate to convert T3 into
3,5-T2, which binds to the long variant of TRβ1 in teleosts [3]. D3 isFig. 1. Intracellular T3 availability and action. Specific TH transporters facilitate the influx as w
deiodinases (Ds) activate or inactivate THs, thereby regulating T3 availability. T3 translocates to
with the retinoic X receptor, RXR) and bind to TH response elements (TREs) in the promoter r
genes where unliganded TRs repress gene transcription, while binding of T3 induces a switch
regulated genes.also a low Km enzyme that catalyses only inner ring deiodination
(IRD) and has T3 as preferred substrate. Its main function is the conver-
sion of T3 as well as T4 into iodothyronines that do not bind to nuclear
TRs. In general, a given cell type expresses either one or two types of
Ds but the number and typemay change several times during ontogeny.
Development in vertebrates can be either direct or indirect. In
mammals, birds and reptiles the process of birth (following internal
development) or hatching (following external development) marks
the direct transition from the embryo to the juvenile, immature adult
form. Amphibians and fish have an indirect development where hatch-
ing is followed by a distinct larval phase separating the embryo and
the juvenile. This review focuses on some well-studied species with
indirect/direct development to illustrate the impact of Ds on each of
the pre-juvenile stages and on the sequential transition from one
stage to the other. Whenever possible, we try to combine information
on D ontogenetic expression patterns with information gained from
gain-and-loss of function studies.
3.1. Indirect development in fish and amphibians
3.1.1. Zebrafish embryos
Embryonic D expression has been studied in detail in zebrafish
(Danio rerio), one of themajor vertebrate models for developmental bi-
ology. Zebrafish embryonic development takes about 3 days and their
thyroid gland starts hormone secretion around hatching [15]. Due to a
whole genome duplication in the early evolution of ray-finned fishes,
zebrafish and several other teleost fish have two dio3 paralogues [16,
17], similar to the presence of two thra paralogues [18].
Maternal mRNA for all three types of Ds is present in the egg and by
the end of the maternal–zygotic transition around 8 h post fertilisation
(8 hpf) embryonic transcripts can be detected and quantified. While
whole body dio1 and dio3mRNA levels increase during the first day of
embryogenesis, dio2 mRNA levels only rise substantially on the third
day, around hatching concomitantwith the start of embryonic TH secre-
tion ([17,19]; and own unpublished results) (Fig. 2). In situ hybridiza-
tion (ISH) results on the tissue-specific expression pattern in zebrafish
embryos have been reviewed recently [20]. At 12 hpf the dio1 and
dio2 signals are colocalized in the head region while the dio3 signal is
found in the kidney. From 24 hpf onwards dio2 is also expressed in
the retina and the adenohypophysis. At 48 hpf dio2 also appears in the
spinal cord and dio1 can be detected in the liver [21–23].
Thanks to the relatively easy method of antisense morpholino injec-
tion [24] loss-of-function studies in zebrafish embryos have been possi-
ble for all three Ds. Knockdown (KD) of D2 clearly delays developmentell as the efflux of T4 and T3 (and some other iodothyronines). Within the cell, different
the nucleus where it binds to TH receptors (TRs). TRs form heterodimers (predominantly
egion of TH-responsive genes. The figure represents the situation for positively regulated
from repression to activation of gene transcription. The opposite occurs for negatively
Fig. 2.Ontogenetic profile ofmRNA levels for TH receptors (thra and thrb) and deiodinases
(dio2, dio3a and dio3b) inwhole body extracts of zebrafish (Danio rerio) embryos and early
larvae up to 7 days post fertilisation (dpf). Data are presented as fold change relative to the
lowest level measured for each separate gene. Pictures representing different develop-
mental stages are shown below the time-axis. Embryos normally hatch between 50 and
70h post fertilisation, indicated by the black bar. Both thrb and dio3b levels increase sharp-
ly on the first 2 days post fertilisation while dio3a and dio2 expression increase sharply
around hatching. dio1mRNA levels are not included in the figure for clarity. They double
by the end of 1 dpf and then remain stable up to 3 dpf (own unpublished results).
Data are taken from [19,41,136].
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length, head-to-trunk angle andpigmentation index. It also significantly
decreases thrb expression [25]. KD of D1 does not have obvious effects
on embryonic development, but combined KD of D1 and D2, blocking
all T4-activating pathways, aggravates the phenotype observed in D2
morphants. Most D1D2 morphants show delayed/aberrant eye devel-
opment (own unpublished results) and some embryos do not develop
an inner ear and/or have severely curved tails [26]. This shows that
while D1may not be essential for embryonic development in euthyroid
zebrafish, it may be important in conditions where T3 availability is re-
duced due to impaired D2 activity. This illustrates the importance of pe-
ripheral T3 production and indicates that liganded TR signalling is
required for normal progression of several essential developmental
processes.
Recently we also published results for KD of both T3-inactivating D3
enzymes, the long known D3b and the more recently identified D3a
[17]. Some of the morphological changes observed before in D1D2
morphants are also present in D3b morphant embryos, including an
overall delay in development and defects at the level of the eye [17].
This suggests that several processes in zebrafish embryonic develop-
ment are highly dependent on the exact balance between unliganded
and liganded TR signalling. Analysis of the transcriptome around hatch-
ing (72 hpf) shows that some changes in gene expression are similar in
D1D2 and D3bmorphants, but there are also many divergent responses
(own unpublished results). We also knocked down D3a and found that
the phenotype is similar but significantlymilder than followingD3b KD.
This could be matched to enzyme activity studies showing that KD of
D3b almost completely abolishes D3 activity in homogenates of 72 hpf
embryos while D3a KD reduces activity by only 22–26% [17]. Results
on morpholino based KD of D3b are also available from anotherresearch group, showing impaired caudal cranial neural crest develop-
ment, and as a result, inhibited development of the posterior pharyn-
geal arches, ceratohyal cartilage and iris stroma [27].
3.1.2. Xenopus embryos
Frog development from fertilisation up to completion of metamor-
phosis is generally divided in a number of consecutive stages based on
morphological features. For Xenopus they have been described in detail
by Nieuwkoop and Faber (NF stages 1 to 66) [28]. In the African clawed
frog (Xenopus laevis) mRNAs of all three Ds are present throughout em-
bryogenesis, showing that in contrast to what was long accepted, the
dio1 gene is also present and transcribed in amphibians [29,30]. dio1
mRNA is the predominant maternal D transcript present in eggs but
levels decline rapidly. Embryonic dio1 mRNA expression sharply in-
creases aroundNF45when the embryonic thyroid gland starts function-
ing. Embryonic dio2 and dio3 mRNA levels increase earlier, starting
respectively aroundNF41 andNF37 [30]. ISH during late embryogenesis
(NF30–40) shows strong expression of the three dio genes in the head
region and axial structures but the expression patterns do not fully
overlap. dio1 expression is strong in the notochord andbranchial arches,
dio2 expression is mainly found around the eye and the neural tube and
dio3 expression is mainly present around the branchial arch areas and
around the eye. It could also be shown that dio2 and dio3 mRNA are
translated into functional proteins (tested at NF37) while the contribu-
tion of D1 to deiodination seems to be minor [29].
ISH studies in the western clawed frog (Xenopus/Silurana tropicalis)
show expression of dio3 but not dio2 in the gastrula. From neurulation
until the embryo–larva transition (stages NF22 to NF36), a dio2 signal is
present in the notochord, brain, retina and the ventral blood-forming
region and dio3 mRNA is consecutively detectable in the ventral
blood-forming region, the retina, the notochord, the pro-nephros and
the otic vesicle [31]. Taken together, the results available from both
Xenopus species indicate that the expression patterns of Ds in embryon-
ic tissues such as brain are highly dynamic [31,32]. Since TRs are also
present in Xenopus embryos from the start of development [33,34],
deiodinases may serve to locally regulate the balance between activa-
tion and inactivation of maternally derived THs and hence the balance
between TR-mediated gene repression and activation [35].
Unfortunately, what we know about the role of Ds in amphibian em-
bryonic development is so far mostly based on correlations. Functional
proof awaits results from embryos lacking or overexpressing specific
Ds, an approach that is technically possible and will hopefully provide
new data in the near future.
3.1.3. Embryo-to-larva transition in zebrafish
One of the major events accompanying the embryo-to-larva transi-
tion in zebrafish is inflation of the swim bladder, important for active
swimming behaviour and feeding. Zebrafish D3bmorphants show a se-
vere delay in swim bladder inflation, although timing of the formation
of the swim bladder anlage seems normal. One hypothesis is that the
delayed inflation is due to the substantially reduced motility observed
in the prehatch embryos and the larvae, reducing their ability to gulp
air at the water surface [17]. THs could also more directly interfere
with swim bladder development, possibly by interaction with the
hedgehog and/or the canonicalwnt signalling pathways. Both pathways
are known to be important regulators of zebrafish swim bladder devel-
opment [36,37] and both have already been linked to THs in other pro-
cesses [38,39]. Changes in D2 and/or D3 activity induced by hedgehog,
as known to appear for instance in differentiating chicken chondrocytes
and in proliferating mammalian keratinocytes [40], may add an addi-
tional level in the interaction of these three signalling pathways and
hence affect swim bladder development in zebrafish, although this hy-
pothesis remains to be tested.
We found a similar but milder defect in swim bladder inflation in
D3a morphants but also in D1D2 morphants. While the latter may
seem surprising, it corresponds with other studies showing that both
Fig. 3.Changes inD2 andD3 activity in different tissues ofmetamorphosing bullfrog (Rana
catesbeiana). Arrows indicate respectively the start of rapid hindlimb growth in early
prometamorphosis (1), the eruption of forelimbs at the start of metamorphic climax (2)
and the start of tail shrinkage (3). D2 and D3 activity peak simultaneously in hindlimb
during growth and increase together in forelimb around emergence. In tail, D2 activity in-
creases sharply when tail shrinking starts while D3 activity peaks earlier.
Developmental stages are indicated according to Taylor and Kollros [137] (TK-stages V to
XXIV) and representative images for some metamorphic changes are taken from [138].
Data are taken from [46].
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zebrafish swim bladder inflation [41]. It might just be another example
of how important the exact balance between TR-mediated gene activa-
tion and repression is for development to progress normally.
3.1.4. Larva-to-juvenile transition in frogs
Amphibianmetamorphosis is probably the best known example of a
developmental process controlled by THs. That is probably also the
reason why much of the pioneering work on the role of peripheral TH
deiodination in development started in this model. It was suggested
already in 1962 that enzymes metabolizing THs might be important
regulators of metamorphosis [42]. Following later studies on ORD
(T3-producing) and IRD (T3-degrading) activity in premetamorphic
and metamorphosing tadpoles, Galton concluded in 1988 that next to
the number of TRs, the balance between ORD and IRD activities in a
given target cell regulates the effectiveness of circulating THs during
metamorphosis [43]. The metamorphosing tadpole was also the first
species where a D3 enzyme was cloned following its identification as
an early response gene in TH-induced tail resorption [44,45].
A detailed analysis of D2 and D3 activity and mRNA expression
during bullfrog (Rana catesbeiana) development subsequently demon-
strated that the timing of major metamorphic changes and highest
dio2mRNA levels/D2 activity coincide in many tissues, including limbs,
tail, intestine, skin and eye. Blocking D2 activity with the deiodinase in-
hibitor iopanoic acid (IOP) clearly retards metamorphic events in these
tissues [46]. The link between dio2 expression andmetamorphic changes
was also made in X. laevis by studying TH-stimulated cell division. Cells
in brain, spinal cord and limbbuds that proliferate in response to low cir-
culating TH levels during the early phase of metamorphosis, constitu-
tively express high levels of dio2 and their response to T4 can be
blocked by IOP treatment [47]. Both cell division and dio2 expression
in these regions decrease at metamorphic climax, when dio2 expression
increases in response to high circulating TH levels in tissues such as in-
testine and tail that do not proliferate but remodel or disappear [47].
The link between the expression pattern of D3 and metamorphosis
seems to be more complex. In several, although not all bullfrog tissues
the timing of greatest metamorphic changes and high dio2 mRNA/D2
activity coincides also with increased expression/activity of the T3-
degrading enzyme D3 [46] (Fig. 3). In contrast, expression of D3 in
X. laevis correlates with a tissue having a reduced response to TH and
D3 is upregulated prior to metamorphic change or just before the
completion of a tissue's response to TH [48]. These findings may be
complementary, illustrating the multiple roles of D3 in tadpole tissues:
(1) reducing TH responsiveness and allowing the action of unliganded
TRs prior tometamorphic changes, (2)fine-tuning intracellular T3 levels
in combination with D2 at the moment of metamorphic changes, and
(3) stopping the liganded TR-induced gene expression programme at
the end of metamorphic changes [46,49].
The crucial impact of D3 on metamorphosis was demonstrated in
transgenic X. laevis tadpoles overexpressing D3. Gill and tail resorption
were clearly delayed and most of the animals arrested metamorphosis
and died [50]. The same research group also showed the impact of D3
in the eye. Prior to metamorphosis, the retina grows symmetrically. As
TH levels start to risewith the onset ofmetamorphosis, themorphology
of the eyes starts changing. Cell proliferation in the ventral ciliary mar-
ginal zone (CMZ) increases and ipsilateral projections to the brain are
formed, concomitant with the change in head shape that allows some
overlap in visualfields. In contrast to the proliferating cells of the ventral
CMZ, cells in thedorsal CMZ express high levels of D3 and fail to respond
to the increase in circulating THs, resulting in asymmetrical retinal
growth [51]. In transgenic tadpoles overexpressing D3 throughout the
body, cell division in the ventral CMZ was reduced and ipsilateral pro-
jections to the brain were not formed [49]. No additional data on trans-
genic tadpoles lacking or overexpressing Ds were published more
recentlywhich is unfortunate, since amphibianmetamorphosis remains
an excellent model to study D involvement in development.3.1.5. Larva-to-juvenile transition in teleost fish
The possible role of THs in larva-to-juvenile transition in fish has
been studied mainly in species where this transition is accompanied
by clear changes in morphology and habitat. One example is flatfish,
where metamorphosis transforms a bilaterally symmetric pelagic larva
into an asymmetric benthic juvenile. TH secretion and TR expression
increase during spontaneous metamorphosis and the process is ac-
celerated by TH supplementation [52–55]. In Senegalese sole (Solea
senegalensis) measurements in whole body extracts show that both
dio2mRNA and D2 activity keep increasing from the start to the end of
metamorphosis (Fig. 4). dio3mRNA levels show a peak at metamorphic
climax, but D3 activity decreases from the start to the end of metamor-
phosis [54]. D2 expression is also high in metamorphosing turbot
(Scophtalmus maximus) [52]. Changes in D expression also occur in the
larva-to-juvenile transition of teleost species that undergo less dramatic
changes, such as sea bream (Sparus aurata). Expression of D1 and D2
starts to increase at the start of metamorphosis, peak at climax together
with TR expression and decline again towards the end of metamorpho-
sis. D3 expression, however, does not change during the process [56].
The increase in ORD anddecrease in IRD activity togetherwith increased
TR availability at the start of metamorphosis suggests that liganded TR
signalling through binding of T3, and possibly 3,5-T2, is a driving force
in teleost metamorphosis.
Results on whole body expression were recently complemented
by tissue-specific ISH data in metamorphosing flounder (Paralichthys
olivaceus) [16]. dio1 expression is localized in the liver and is restricted
in time fromprometamorphosis to early climax; it is thought to be impor-
tant for supply of T3 to the blood. dio2 is expressed in eye, tectum and
skeletal muscles throughout metamorphosis. dio3 is expressed from
premetamorphosis until early climax in several tissues, including skeletal
muscle and the developing stomach [16]. As is the case in amphibians,
these expression patterns suggest that the three types of Ds are specific
and important regulators of larva-to-juvenile transition in teleosts.
3.2. Direct development in reptiles, birds and mammals
Birds and most reptiles have an external development where the
hatching process marks the transition from the embryonic to the
Fig. 4. Ontogenetic profile of mRNA levels for TH receptors (thraa2 and thrb2) and
deiodinases (dio2, dio3) as well as deiodinase activities (D2 and D3) in whole body ex-
tracts of metamorphosing flatfish (Solea senegalensis). Data are presented as fold change
relative to the lowest levelmeasured for each separate gene.Metamorphosis starts around
12 days post fertilisation (dpf) and is completed by 21 dpf. Expression of both TH receptor
isoforms peaks in the second half of metamorphosis. dio2 expression and D2 activity con-
tinue to increase up to the end ofmetamorphosiswhile D3 activity gradually declines from
early to late metamorphosis despite a transient peak in dio3 expression.
Representative images of sole developmental stages have been taken from [139]. Data are
taken from [54].
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supporting, this is not the case in many birds. Songbird hatchlings are
poorly developed and completely dependent on parental care for sur-
vival. Songbirds and several other bird species are called altricial, in con-
trast to precocial birds like chickens and ducks where hatchlings are
mobile and capable of finding food. This difference in precocial versus
altricial development clearly coincides with differences in timing of
the start andmaturation of TH secretion and peripheral THmetabolism,
suggesting there is a link [57,58]. For mammals too, we can identify al-
tricial species like rodents and precocial species like ungulates although
many species, including humans, should be classified somewhere in be-
tween. Typicalmodel species for both types of development are the pre-
cocial chicken and the altricial mouse.3.2.1. Chicken embryo
Chicken embryonic development takes 3 weeks; the thyroid gland
starts hormone secretion after approximately 7 days of incubation
(E7) and is fully functional around E12 [59]. Studies on TH deiodination
in avian embryos started in the 1980s by in vitro characterization of
ORD and IRD activities in chicken embryonic liver and heart [60–62].
It was shown by several groups that a decrease in hepatic IRD activity
in the last days prior to hatching is a major factor contributing to the
sharp increase in circulating T3 that precedes hatching [60,61,63]. Fol-
lowing the identification and cloning of the three D types in chicken,
their expression pattern was studied during the third and last week of
embryonic development using Northern blot and in vitro kinetic tests.
These techniques showed that D3 (mRNA and activity) is most widelypresent, followed by D1, while D2 expression seems to be restricted
mainly to brain [64].
Studies with themore sensitive RT-PCR and ISH techniques are only
available for some embryonic tissues. Our own research group focused
on brain development. mRNA for all three Ds is present in brain from
the first stage studied, namely 4-day-old embryos (E4), but unlike
DIO2 and DIO3, DIO1 mRNA does not seem to yield an active enzyme.
DIO2mRNA and D2 activity gradually increase in all major brain regions
from E4 to E12 while the patterns for DIO3/D3 are more variable
amongst brain regions [65]. This fits with ISH data from E3 to E10 show-
ing that DIO2 is expressed throughout the brain, predominantly associ-
ated with blood vessels, while it is absent in the choroid plexus at this
time [66,67]. In contrast, high DIO3 expression is specifically localized
in the choroid plexus and in a limited number of cell populations, in-
cluding several brain regions involved in the development of the visual
system [66].
Dynamic and cell-specific changes also occur at the protein level, as
demonstrated for all three Ds by immunohistochemistry (IHC) in cere-
bellum in the days around hatching. For instance, E18 Purkinje cells
stain weakly positive for D2 but not for D3 while in 1-day-old chicks
they stain strongly positive for D3 only. This shift is accompanied by a
strong decrease in the presence of reelin and Dab-1 proteins, both prod-
ucts of TH-responsive genes [68]. Another example is found at the level
of the choroid plexus. While DIO3 mRNA and D3 protein expression
dominate in early embryonic stages, there is a transient increase in
DIO2/D2 expression in the days just prior to hatching ([69] and own un-
published results). This could be an additional source for T3 entry into
the brain in the last days of embryonic development, when major
maturation processes take place. Since this coincides with a period of
increased expression of THRB, especially in cerebellum, signalling via
liganded TRβ seems to be important for perinatal glial and neuronal
maturation [70].
Developing chicken eye and ear show a highly dynamic expression
pattern of D2 and D3, comparable to what has been observed in mice
(see below). While DIO3 mRNA is already present in chicken retina at
E3, DIO2 only appears around E6 in the outer neuroblastic layer. At
E8,DIO2 is expressed in the outer nuclear layer, presumably in develop-
ing photoreceptors, while DIO3 is mostly confined to the inner nuclear
layer, presumably associated with retinal progenitor cells (Fig. 5). By
E10, DIO2 expression is restricted to the area adjacent to the lens
[66,71]. The peak in DIO2 expression in the immature photoreceptor
layer coincides with a peak in THRB expression suggesting that D2-
mediated TRβ activity is necessary for specific stages in photoreceptor
differentiation [71]. Ds probably also have a role in development of
the cornea which gradually becomes transparent from E12 to E20.
This transformation coincides with a gradual increase in expression of
THRB and DIO3 while DIO2 expression peaks at the time the process
starts and declines thereafter. THRA and DIO1 expression on the other
hand remain constant [72]. In the inner ear, DIO2 expression starts at
E6 and gradually increases during development while no DIO3 expres-
sion has been detected by ISH [66].
For peripheral tissues, the cellular distribution of D1 and D3 proteins
has been described in liver and kidney [73]. In the last week of embry-
onic development, high levels of both Ds are present in a thin layer of
hepatocytes around the blood vessels. In kidney, D1 and D3 are found
in several cell types, including the tubular epithelial cells. This could
mean that a tight regulation of T3 is necessary for correct tubular func-
tion but it could also reflect a function of these cells in the recuperation
of iodine from the renal filtrate. A study in embryonic chick tibial
growth plates has shown that D2 is expressed in chondrocytes and
that there is a direct interaction between the hedgehog and TH-
signalling pathway at that level [40]. A local increase in Indian hedgehog
leads to increased D2 degradation via the ubiquitination pathway,
resulting in a reduction of local T3 production. This leads to an induction
of parathyroid hormone-related peptide, which in turn will control the
transition from chondrocyte proliferation to differentiation [74].
Fig. 5. Distribution pattern of DIO2, DIO3 andMCT8mRNA shown by ISH in the retina
of 8-day-old chicken embryos. Positive layers (dark blue) are identified in white letters,
other layers are identified in black. The image for D2 is from a peripheral area in the retina
(near the lens) where D2 expression is highest. The images for D3 andMCT8 are from the
central retina (near the optic nerve). Scale bars represent 100 μm. GCL: retinal ganglion
cell layer, INL: inner nuclear layer, OFL: optic fibre layer, ONL: outer nuclear layer, RPE:
retinal pigment epithelium.
135V.M. Darras et al. / Biochimica et Biophysica Acta 1849 (2015) 130–141While the above interactionwith Indian hedgehog is an example of a
localized influence on Ds and T3 availability, some hormones from out-
side the thyroidal axis are changingD expressionwith consequences for
circulating T3 levels throughout the body. A good example is the in-
crease in circulating T3 prior to hatching. Both growth hormone and
corticosterone (or its synthetic analogue dexamethasone) acutely shut
down DIO3 gene expression in embryonic chicken liver [75]. Liver is
responsible for a substantial part of peripheral T3 production and degra-
dation, and hepatic D3 activity is very high until some days before
hatching [63]. Injection of growth hormone or glucocorticoids at that
stage rapidly decreases hepatic D3 activity and hence increases plasma
T3 [76,77]. The rise in plasma growth hormone and corticosterone
starting a few days before hatching therefore seems to be a determining
factor in the rise in plasma T3, necessary for hatching [63,78]. Glucocor-
ticoids also have an effect in embryonic brain where they decreaseDIO3
and increase DIO2 gene expression [75] resulting in local changes in T4
and T3 availability [79]. This regulatory role of glucocorticoids may be
important in vertebrate development in general, since they induce sim-
ilar changes in D expression in larval (neotenic) axolotls (Ambystoma
mexicanum) and at least partially also in bullfrog tadpoles and rat
foetuses [80,81]. The effect is however stage dependent, and glucocorti-
coid treatment tends to decrease plasma T3 in posthatch/postnatal birds
and mammals both by central and peripheral actions [76,80,82].
Although the above examples of interaction with Ds already show
that these enzymes help in regulating chicken embryonic developmentand the transition from the embryonic to the posthatch stage, studies
with DIO gene silencing or overexpression would be very helpful in elu-
cidating the specific role of each one of the Ds. In vivo KD by RNAi-
induced silencing is a possible approach. It has already been proven suc-
cessful for KD of D2 expression in chicken retina. Unfortunately, the
authors only used it as a proof of principle and did not discuss the
resulting effects on retinal development [83]. This would have been
very interesting for comparison with the eye phenotype observed in
D2 knockout mice (see below).
3.2.2. Prenatal and neonatal mouse
Rat and mice were amongst the first vertebrates where peripheral
deiodination was investigated, starting in the 1950s [84], but for long
the studies mainly focused on postnatal life stages. This might be linked
to the intra-uterine development, making experimental manipulations
in embryonic/foetal rodents less easy, but also to the fact that the thy-
roid gland in rodents develops late. Foetal TH secretion only starts in
the third and last week of intra-uterine development and the thyroid
axis only matures by the end of the first postnatal week [85,86]. This
is linked to their altricial development and many developmental pro-
cesses that occur prior to birth in more precocial mammals can be stud-
ied postnatally in rodents. With the ever increasing possibilities of
complete as well as conditional deiodinase knockout (DKO), the num-
ber of developmental studies in mice has increased exponentially over
the last 10 years and several of them now also include prenatal stages.
One factor complicating the study of Ds and DKO inmice is thatDio3
is an imprinted gene [87]. Genomic imprinting is an epigenetic phe-
nomenon in mammals that affects a small number of genes and results
in the preferential expression of one of both alleles, depending on the
parental origin [88]. The imprinted gene cluster containing Dio3 is nor-
mally expressed from the paternally inherited chromosome, but the
maternal Dio3 allele does not seem to be completely silenced. Dio3 im-
printing is not complete in the placenta and its expression can be bi-
allelic or even maternally inherited in certain areas of the brain [89].
Maternal transfer of THs to the developing embryo/foetus occurs via
the placenta. It was originally thought that rodent prenatal tissues con-
tain only low levels of T3 because foetal TH secretion starts late and the
high IRD activity in placenta limits maternal T3 transfer [90]. However,
the distribution pattern of Ds allows the foetus to increase or decrease
T3 availability in a tissue-specific way and also to compensate at least
partially for changes in maternal TH supply [91]. In rat foetal liver, kid-
ney, intestine, lung and eye, the principal TH-activating enzyme is D1,
while D2 is the principal TH-activating enzyme present in brain and
the only D present in brown adipose tissue. Foetal skin expresses all
three Ds. D3 activity levels are high in many foetal tissues, including
liver, brain, intestine and skeletal muscle. In general, D3 levels tend to
decrease towards birth while D1 and D2 levels increase [92,93].
Our understanding of the role of specific Ds in the development and
maturation of different tissues has greatly improved by the study of
DKOmice. These models prove, somewhat surprisingly, that foetal sur-
vival is possible without expression of any activating D [94]. The same is
true for D3 deficiency, although this is accompanied by partial neonatal
lethality [87]. More detailed studies of the phenotype of D1KO mice
showmarked changes in the metabolism and excretion of THs, but pro-
vide little evidence for amajor role of D1 inmouse development [14,92].
In contrast, D2KO and especially D3KO mice show developmental ab-
normalities in several tissues, some of them leading to life-long deficits.
D2KO mice have normal plasma levels of T3 but increased levels of
T4 and thyrotropine (TSH) as a result of pituitary resistance to T4 [95].
D3KO mice show a complicated pattern of thyroid function. They
show a several-fold increase in plasma T3 compared to wild type both
in utero and in the neonatal period, due to a reduced T3 clearance rate
[96]. However, frompostnatal day 15 up to adulthood they demonstrate
central hypothyroidism with low plasma T3 and T4 levels, suggesting
that the neonatal thyrotoxicosis has severely disturbed the maturation
of the hypothalamo-pituitary-thyroid axis [96].
136 V.M. Darras et al. / Biochimica et Biophysica Acta 1849 (2015) 130–141Although TH levels in circulation of D2KOmice are sufficient, local T3
signalling is reduced in several tissues. D2 deficiency lowers the expres-
sion of TH-responsive genes, including Pgc-1α and Ucp1, in embryonic
brown adipose tissue. This results in impaired differentiation and oxida-
tive capacity of brown adipocytes, and results in permanent defects in
adaptive thermogenesis [97]. Local T3 production by D2 is also impor-
tant for muscle development. Dio2 is expressed in proliferating muscle
progenitor cells and increases markedly during differentiation as a re-
sult of an increase in the transcription factor FoxO3.Myotube formation
is blocked in myoblasts of D2KO mice and the normal myogenic pro-
gramme, including induction ofMyoD,myogenin andMHC, is inhibited.
This affects muscle development as well as muscle regeneration after
injury [98]. It has been found recently that the increase in D2 expression
in differentiating myoblasts involves an epigenetic control mechanism
via the lysine-specific demethylase enzyme LSD-1 which relieves the
repressive marks on the Dio2 promoter. This enzyme also leads to
a downregulation of D3 due to removal of activation marks on the
Dio3 promoter [99]. Both processes contribute to increased local T3
availability.
The bones of adult D2KO mice have reduced toughness and are
brittle, due to increased skeletal mineralization. However, investigation
of the skeleton of D2KOmice at birth reveals no abnormalities, and en-
dochondral ossification in D2KOmice is normal [100]. This is consistent
with the finding that, in contrast to chicken, mouse growth plate
chondrocytes do not seem to possess D2 activity, while the foetal
growth plate expresses high levels of Dio3 mRNA that decrease sub-
stantially towards birth [101,102]. The adult brittle bone phenotype
therefore does not seem to be a consequence of abnormal skeletal de-
velopment [100].
D2KO and D3KO mice also show changes in carbohydrate and lipid
metabolism.Dio3 is highly expressed in embryonic aswell as adult pan-
creatic islets, predominantly in β cells, whileDio1 andDio2mRNA levels
are very low. Neonatal D3KOmice have a reduced β cell mass, reduced
insulin production and impaired expression of several key β cell genes.
This developmental defect persists throughout life and leads to dis-
turbed glucose homeostasis [103]. Glucose homeostasis is also dis-
turbed in D2KO mice which show insulin resistance [104]. In addition,
they have an increasedweight gain compared towild typewhen placed
on a high fat diet, a characteristic that might be linked to impaired
brown adipose tissue development and function as mentioned above.
Although D2KO and D3KO mice do not show a severe neurological
phenotype at first sight, more detailed behavioural studies start to re-
veal smaller defects, e.g. the impaired ability to invert and descend a
vertical pole [105,106]. The possible link of D deficiency with the struc-
tural development of ear, eye and brain has been studied to a large ex-
tent during the first postnatal weeks, consistent with the relatively
late maturation of the rodent brain and sensory systems. Expression of
Dio3 is high in the immature prenatal cochlea and decreases in the
first days after birth. In contrast, Dio2 expression is very low in prenatal
cochlea but increases sharply in the first postnatal week, prior to the
onset of hearing in the secondweek [107]. D2deficiency delays cochlear
development while D3 deficiency accelerates the process. However,
both conditions lead to impaired development of the sensory epitheli-
um and permanent deafness [108,109]. The cellular expression pattern
of D3 partly overlaps with that of TRβ, the receptor that is primarily
responsible for auditory development [109]. These studies are a clear
example of how essential local changes in the balance between TH acti-
vation and inactivation are, but also of the fact that these changes have
to occur within a critical time window to ensure normal development.
Correct T3 signalling is also important for eye development. D3 activ-
ity levels are high in prenatal mouse retina while little or no D1 or D2
activity can be detected, suggesting that D3 has a protective role at
these stages [110]. The number of cones, the photoreceptors for daylight
and colour vision, is greatly reduced in the retina of adult D3KO mice.
This has been linked to an excessive T3 signalling via TRβ2, leading to
a high but transient increase in cell death of cones in the first postnataldays. The number of rods,whichmediate dim light vision and donot ex-
press TRβ2, remain normal [110].
Some studies have already shown changes in brain development
mainly at the level of gene expression, although a lot remains to be ex-
plored. In the first days after birth, T3 content is significantly increased
in D3KO brain, resulting in increased expression of TH-responsive
genes such as Hairless and RC3 [96]. By two weeks after birth, when pe-
ripheral TH levels have dropped, the picture seems to bemore complex.
Studies with a transgenic mousemodel (FINDT3), expressing β galacto-
sidase as a readout of local T3 availability, have shown that by that time
some brain regions still have increased T3 levels, while T3 levels in some
other regions have already decreased [111]. This indicates that D3 has
an important and region-specific role in regulating T3 signalling in the
developing brain. T3 content in the neonatal D2KO brain is markedly re-
duced.Nevertheless, expression of several TH-responsive genes is not or
only mildly affected, suggesting that compensatory mechanisms must
occur, limiting the impact of D2 deficiency [105]. A recent study on
the expression of cerebral cortex genes in 4-week-old mice indicates
that the impact of D2 and D3 deficiency is higher on negatively regulat-
ed TH-responsive genes than on positively regulated ones [112]. Finally,
a recent study on cerebellum shows that D2 activity is very low in the
late foetal stages and at birth but increases during the first postnatal
week, while D3 activity is relatively high prenatally and starts to de-
crease 3 days after birth [106]. As a consequence of aberrant timing of
T3 signalling, D3KO mice show several abnormalities in cerebellar de-
velopment, including reduced foliation, accelerated disappearance of
the external germinal layer and premature expansion of the molecular
layer. Combined deletion of the TRα1 substantially corrects the cerebel-
lar phenotype but for instance not the deafness of D3KO mice where
TRβ signalling is important. This illustrates that the combined expres-
sion of D3 and specific receptor isoforms is controlling development of
different tissues [106].4. TH transporters and vertebrate development
Although it was accepted for long that THs enter the cell by simple
diffusion, it is now clear that their passage through the plasma mem-
brane depends on specific transmembrane transporter proteins. Thy-
roid hormone transporters belong to different transporter families:
the Na+/taurocholate cotransporting polypeptide (NTCP) family, the
Na+ independent organic anion transporting polypeptide (OATP)
family, the L-type amino acid transporter (LAT) family and the mono-
carboxylate transporter (MCT) family [113]. The transporters with
the highest affinity for THs are MCT8 (encoded by slc16a2), MCT10
(encoded by slc16a10) and OATP1C1 (encoded by slco1c1). The general
picture coming from the few species studied is that MCT8 and MCT10
efficiently transport T4 and T3. Rat (but not human)MCT8 also efficient-
ly transports rT3 and 3,3′-T2. OATP1C1 shows preferential transport of
T4 and rT3 [114]. Other transporters that also seem to be of physiological
importance are LAT1 (encodedby slc7a5) and LAT2 (encoded by slc7a8),
but they transport T3 and T4 with a much lower affinity [113]. It is im-
portant to take into account that all these transporters do regulate not
only TH entry into the cell but also TH efflux, allowing passage of acti-
vated hormone from one cell type to another [114].
A clear proof for the essential role of TH transporters in development
was the discovery that the human Allan–Herndon–Dudley syndrome,
characterized by hypotonia, weakness, reduced muscle mass, severe
mental retardation and several other neurological symptoms, is linked
to mutation of the MCT8 gene [115,116]. Studies in MCT8KO mice
were started soon after this discovery, but the neurological phenotype
is quite different from that in humans [117,118]. This could be due to
the differences in the cellular distribution pattern of different TH trans-
porters between human and rodent brain [119,120] and shows the need
for additional animal models. Our knowledge on TH transporters in
non-mammalian vertebrates has started to grow during the last years
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the impact of MCT8 deficiency in developing human brain.4.1. Non-mammalian pre-juvenile stages
The first, and to our knowledge, the only TH transporter that has
been functionally characterized in fish is the zebrafish Mct8 [121]. An
interesting feature is that although zebrafish Mct8 transports T4 and
T3 when tested in cell culture at 37 °C, it only transports T3 when tested
at 26 °C, which is close to the normal body temperature in zebrafish.
The authors showed that the mct8 gene is expressed in a wide variety
of tissues in adult zebrafish and that mct8 mRNA is also present in ex-
tracts of whole embryos, with a peak at 48 hpf [121]. Results of whole
mount ISH show that mct8 mRNA is ubiquitously present in embryos
at 10 hpf, but gradually becomes restricted to the brain and spinal
cord by 48 hpf [23]. With the same technique, expression of oatp1c1 at
48 hpf is only observed in vascular structures within the brain, while
mct10 expression is limited to the liver and the trigeminal ganglia
[23]. Colocalisation studies of Mct8 and different cell-specific markers
in transgenic zebrafish larvae, carrying a fluorescentmct8 reporter con-
struct, indicate thatmct8 is expressed in neurons and oligodendrocytes
but not in astrocytes, similar to the situation in mice. mct8 is also
expressed in blood and lymph vessels in the trunk, in several brain
veins and blood vessels surrounding the brain, but not in the arteries
at the level of the blood–brain barrier nor in the choroid plexus, which
is different from the situation in rodents [23].
The same research group has used morpholino KD to study the role
of Mct8 in zebrafish development. Their results show that at 48 hpf,
Mct8 morphants have a deformed brain, spinal cord and notochord,
while the development of muscles and the vascular system seems unal-
tered [23]. In contrast, using the same approach, another research group
recently found that next to defects in brain development, Mct8 KD also
results in clear abnormalities in vascularisation, particularly at the level
of the eye and thebrain. In addition, theirMct8morphants showa clear-
ly reduced locomotor activity [122]. Also recently, the expression pat-
tern of several TH transporters has been reported in another teleost
fish, the fathead minnow (Pimephales promelas), but only at the adult
stage [123].Fig. 6.Ontogenetic profile ofmRNA levels for TH transporters (mct8,mct10, oatp1c1 and lat1) in
fold change relative to the lowest levelmeasured for each separate gene. The start of rapid hindli
early in gill resorption while the other transporters peak at the end. The expression of transpo
Developmental stages are indicated according to Nieuwkoop and Faber [28] (NF-stages 53 to 64
from [28] (digitized on Xenbase) and [140] respectively. Data are taken from [124].In amphibians, the expression pattern of TH transporters has been
studied by RT-PCR in different tissues of metamorphosing X. tropicalis
from pre-metamorphosis towards the end of metamorphic climax
(NF53 toNF64) [124]. In general,mct8 andmct10 seem to bemost abun-
dantly expressed but the temporal expression pattern of most trans-
porters varies between tissues, in correlation with the timing of their
metamorphic changes [124] (Fig. 6). Growth in hindlimbs seems to be
associated with high levels of mct8 and mct10 and transient peaks in
oatp1c1 and lat1mRNA. The expression ofmct8 in tail increases strongly
throughout its regression and alsomct10 and lat1mRNA levels increase.
In gillmct8,mct10 and oatp1c1 expression only increase towards the last
stages of resorption.mct8, mct10 and lat1 expression increase in meta-
morphosing kidney, while metamorphosis in liver is accompanied by
a strong decrease in mct8mRNA. It is surprising that no major changes
have been observed in TH transporter expression in the metamorphos-
ing brain, but theymay occur in a region-specific way and therefore not
be detectable in whole brain extracts [124]. It can be concluded that
changes in cellular TH uptake and efflux are indeed another important
level for the local regulation of nuclear TR-mediated signalling during
amphibianmetamorphosis. It would certainly be interesting to start ex-
periments with KD of transporters, especially Mct8 and Mct10, in this
developmental model.
Chicken OATP1C1 has been cloned and characterized some years
ago, showing that it is a T4-specific transporter [125]. Our own group re-
cently clonedMCT8,MCT10, and LAT1 and functional characterization is
ongoing. Chickens, aswell as someother investigated birds, seem to lack
the gene for LAT2 (own unpublished results). We have investigated the
distribution pattern ofMCT8 and OATP1C1 in early chicken brain by RT-
PCR. Both transporters are expressed from the earliest stages studied
(E4) but while MCT8 mRNA increases in all major brain regions from
E4 up to E10, OATP1C1 mRNA in telencephalon and diencephalon
shows the reverse pattern [65]. This agrees with our ISH results, show-
ing that MCT8 is widely expressed in neurons throughout the brain
while clear expression of OATP1C1 is restricted to specific areas, such
as choroid plexus, hypothalamus and adenohypophysis. Unlike in
zebrafish, MCT8mRNA is also found in developing choroid plexus, but
similar to zebrafish, it is absent from the microvessels in the brain
forming the blood–brain barrier [66]. The only TH transporter present
at the blood–brain barrier in embryonic chicken seems to be LAT1different tissues ofmetamorphosing clawed frog (Xenopus tropicalis). Data are presented as
mbgrowth is accompanied bypeaks in the expression of all transporters. Lat1mRNApeaks
rters in the resorbing tail shows a variable pattern.
) and representative images ofmetamorphic changes in hindlimb and tail have been taken
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in the retina (Fig. 5) and levels increase from E4 to E8. In de developing
ear, the sites ofMCT8 expression colocalize with those of DIO2, suggest-
ing local cooperative actions between T3 production and transport. ISH
did not reveal expression of OATP1C1 in developing eye or ear [66].
4.2. Prenatal and neonatal mouse
Mct8, Lat1, and Lat2, but not Oatp1c1 mRNA have been detected by
qPCR in femurs of prenatal mice from the first stage studied, namely
14.5-day-old embryos (E14.5).Mct8 expression gradually decreases as
bone development progresses while expression of the other two trans-
porters remains stable, a pattern suggesting that MCT8 may be an im-
portant regulator of bone development and osteoblast differentiation
[126]. MCT8 is also expressed in mouse placenta and MCT8 deficiency
provokes some subtle changes in foetoplacental growth [127]. Studies
in juvenile/adult mice have also shown interesting expression patterns
for TH transporters in other peripheral tissues such as kidney and intes-
tine [128], but data from prenatal and early postnatal stages are lacking.
A dynamic expression pattern for TH transporters is present in de-
velopingmouse brain.MCT8was first studied by ISH, showing predom-
inantly neuronalMct8 expression in the forebrain at E18 [129]. A qPCR
study in developing mouse brain from E15 up to postnatal day 20
(P20) showed that mRNA levels forMct8, Oatp1c1, Lat1 and Lat2 in hip-
pocampus increase during embryogenesis, continue to rise until P5 and
then decline again towards P20, while expression of Mct10 remains
stable (Fig. 7). Similarly, a peak is present inMct8, Lat1 and Lat2 expres-
sion in neocortex and cerebellum around days P5–P10 [130]. For com-
parison, qPCR on rat cerebral cortex from late foetal to early postnatal
stages also shows a postnatal decrease in Mct8, but an increase in
Oatp1c1 and Lat2 expression [131]. Results from a transgenic mouse
line carrying anOatp1c1 reporter construct indicate thatOatp1c1 is tran-
siently expressed in neuronal progenitors in embryonic mouse cortex
but absent in adult neurons, while its expression in blood vessels and
choroid plexus is sustained from embryonic development to adulthood
[132]. The cell-specific distribution of LAT1, LAT2 and MCT8 has been
studied at the protein level in primary cultures of different cell types
from E16 mouse brain. MCT8 is most abundant in neurons, but detect-
able in all cell types except microglia. The distribution pattern is similarFig. 7.Ontogenetic profile ofmRNA levels for TH transporters (mct8, oatp1c1, lat1 and lat2)
in mouse hippocampus from embryonic day 15 (E15) up to postnatal day 20 (P20). Data
are presented as fold change relative to the lowest level measured for each separate gene.
mct8mRNA levels peak shortly before birth while oatp1c1 and lat2 expression continue to
rise up to one week after birth. mRNA levels formct10 remain stable throughout this pe-
riod and are not included in the figure.
Representative images for the developmental changes occurring at the level of the hippo-
campus have been taken from the Allen Brain Atlas portal (Allen Institute for Brain Science)
[141]. Data are taken from [130].for LAT1. LAT2 is most abundant in microglia and also present in astro-
cytes and neurons, but not in oligodendrocytes and endothelial cells
[130]. MCT8 and OATP1C1 proteins have been detected in the cerebral
cortex and at the level of the choroid plexus in rat foetuses at E21
[131]. The functional implications of the specific cellular distribution
pattern of each TH transporter in the developing rodent brain is only
partly understood, but it can be assumed that they function both individ-
ually and cooperatively in distributing active and inactive iodothyronines
amongst proliferating and maturing brain cell populations.
The cell-specific expression pattern of the different TH transporters
in developing mouse cochlea suggests that, together with the Ds, they
are important in timing the access of T3 to the differentiating cells.
LAT1 is strongly expressed in cochlear blood vessels and may facilitate
uptake of THs from the general circulation. OATP1C1 colocalizes with
D2 in fibrocytes and may stimulate uptake of T4 for conversion into T3.
MCT8 expression partly overlaps with TRβ, the predominant TR in the
cochlea, and may be needed for cellular uptake of T3 and subsequent
liganded TR-mediated action [133]. Data on TH transporter expression
in themouse eye are still missing, but given the recent data onMCT8 ex-
pression in embryonic chicken retina (see above), they will almost cer-
tainly have a regulatory role in the development of that sensory system
too.
KOmice have been created for all known TH transporters. So far they
have been studied predominantly in juvenile/adult stages. Interestingly,
a recent study in perinatal MCT8KO mice reveals some striking differ-
ences with the adult phenotype. At the peripheral level, adult
MCT8KO mice have reduced plasma T4 but increased plasma T3 and
liver T3 content. In brain, T4 and T3 content are decreased, accompanied
by an increase in D2 and a decrease in D3 as a compensatory response to
the hypothyroid status [117,118]. Surprisingly, perinatal MCT8KO mice
have higher plasma T4 thanwild type littermates from E18 up to P0 and
thereafter plasma T4 levels in KO and wild type pups are similar at least
up to P7. This transient increase is accompanied byhigher tissue content
of T4 and T3 and higher expression levels of some TH-responsive genes
in both cerebral cortex and liver. The fact that this hyperthyroid status in
brain is accompanied by increased expression of Oatp1c1, Lat1 and/or
Lat2 suggests that these transporters compensate for the lack of MCT8
and increase TH uptake into the brain [134]. Indeed, the recent descrip-
tion of aMCT8/OATP1C1 double KOmouse showed that these mice suf-
fer from impaired and delayed brain development, indicative of a severe
hypothyroid status [135]. The above results illustrate that due to the
interaction of ontogenetic changes at different levels of the thyroid sys-
tem, TH availability and action may be substantially different in devel-
oping compared to mature KO animals, as has also been found before
in developing D3KO mouse [96].
5. Conclusion
The tissue- and stage-specific expression patterns of Ds observed in
the development of different vertebrates are a strong indication that TH
activation and inactivation by these enzymes is an essential step in con-
trolling the intracellular availability of T3 (and in teleosts also 3,5-T2)
and hence TR-mediated signalling. Studies following D knockout/knock-
down or overexpression in three different vertebrate models, namely
zebrafish, Xenopus and mouse, have now also provided functional proof
for the involvement of Ds in the development of a variety of organs. It
is interesting to notice that in general, deficiency of the TH-inactivating
enzyme D3 seems to result in the most severe phenotype, suggesting
that a premature switch from unliganded to liganded TR action is often
more detrimental than a delayed one. In this regard it would certainly
be interesting to study in more detail early embryonic stages in KO
mice, since studies in other vertebratemodels are underlining the impact
of changes in these early stages on further development and later life. It is
also interesting to see that many cell-specific expression patterns have
been conserved throughout vertebrate evolution, as found for instance
for eye and ear development where changes in Ds seem to be linked to
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TH transporters is also increasing rapidly. As a consequence of the link
found in humans between MCT8 mutation and the severe AHD syn-
drome, research on the role of TH transporters so far mainly focused on
brain development. We should however not neglect their role in devel-
opment of other structures andmore research, including studies inmeta-
morphosing species, is needed.
Although substantial information on the ontogenetic distribution
pattern and function of TH receptors, deiodinases, and TH transporters
is now available, we are far from exactly understanding how they
work together in regulating TR-dependent gene repression and activa-
tion in developing tissues. Studies in vertebrates where whole body ex-
pression of one or more of the players has been silenced by gene
knockout/knockdown have started to provide essential pieces of the
puzzle. The next and essential step is to create models with conditional
silencing that can be restricted in a tissue- and time-specific way. This is
already ongoing inmice andwith the recent progress inmolecular tech-
niques other vertebrate models will hopefully follow soon.References
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